Properties of FDA-approved small molecule protein kinase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Properties of FDA-approved small molecule protein kinase inhibitors

Published:2019-06 Issue: Volume:144 Page:19-50
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Roskoski Robert

Publisher

Elsevier BV

Subject

Pharmacology

Reference223 articles.

1. A historical overview of protein kinases and their targeted small molecule inhibitors;Roskoski;Pharmacol. Res.,2015

2. Protein kinases – the major drug targets of the twenty-first century?;Cohen;Nat. Rev. Drug Discov.,2002

3. PKIDB: a curated, annotated and updated database of protein kinase inhibitors in clinical trials;Carles;Molecules,2018

4. Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview;Fischer;Med. Res. Rev.,2017

5. The protein kinase complement of the human genome;Manning;Science,2002

Cited by 393 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and pharmacological evaluation of novel thiazole derivatives as c-Met kinase inhibitors and anticancer agents;Journal of Molecular Structure;2024-12

2. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09

3. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

4. Nitidine chloride inhibits mTORC1 signaling through ATF4-mediated Sestrin2 induction and targets IGF2R for lysosomal degradation;Life Sciences;2024-09

5. Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3